HomeComparePBE vs MCD

PBE vs MCD: Dividend Comparison 2026

PBE yields 1.11% · MCD yields 2.35%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MCD wins by $57.3K in total portfolio value
10 years
PBE
PBE
● Live price
1.11%
Share price
$78.29
Annual div
$0.87
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.3K
Annual income
$118.95
Full PBE calculator →
MCD
McDonald's Corporation
● Live price
2.35%
Share price
$308.53
Annual div
$7.26
5Y div CAGR
42.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$78.5K
Annual income
$26,227.70
Full MCD calculator →

Portfolio growth — PBE vs MCD

📍 MCD pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPBEMCD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PBE + MCD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PBE pays
MCD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PBE
Annual income on $10K today (after 15% tax)
$94.10/yr
After 10yr DRIP, annual income (after tax)
$101.11/yr
MCD
Annual income on $10K today (after 15% tax)
$200.01/yr
After 10yr DRIP, annual income (after tax)
$22,293.55/yr
At 15% tax rate, MCD beats the other by $22,192.44/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PBE + MCD for your $10,000?

PBE: 50%MCD: 50%
100% MCD50/50100% PBE
Portfolio after 10yr
$49.9K
Annual income
$13,173.33/yr
Blended yield
26.40%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MCD right now

PBE
No analyst data
Altman Z
3.7
Piotroski
3/9
MCD
Analyst Ratings
37
Buy
23
Hold
1
Sell
Consensus: Buy
Price Target
$351.76
+14.0% upside vs current
Range: $320.00 — $385.00
Altman Z
4.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PBE buys
0
MCD buys
0
No recent congressional trades found for PBE or MCD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPBEMCD
Forward yield1.11%2.35%
Annual dividend / share$0.87$7.26
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%42.3%
Portfolio after 10y$21.3K$78.5K
Annual income after 10y$118.95$26,227.70
Total dividends collected$1.2K$58.5K
Payment frequencyquarterlyquarterly
SectorStockConsumer Discretionary

Year-by-year: PBE vs MCD ($10,000, DRIP)

YearPBE PortfolioPBE Income/yrMCD PortfolioMCD Income/yrGap
1← crossover$10,811$110.71$10,815$334.85$4.00MCD
2$11,679$111.85$11,826$491.71$147.00MCD
3$12,610$112.93$13,123$730.06$513.00MCD
4$13,606$113.95$14,853$1,100.07$1.2KMCD
5$14,674$114.92$17,257$1,690.61$2.6KMCD
6$15,817$115.82$20,752$2,667.01$4.9KMCD
7$17,041$116.68$26,103$4,354.83$9.1KMCD
8$18,351$117.48$34,794$7,437.78$16.4KMCD
9$19,754$118.24$49,926$13,461.60$30.2KMCD
10$21,255$118.95$78,550$26,227.70$57.3KMCD

PBE vs MCD: Complete Analysis 2026

PBEStock

The Invesco Biotechnology & Genome ETF (Fund) is based on the Dynamic Biotech & Genome Intellidex Index (Index). The Fund will normally invest at least 90% of its total assets in the securities that comprise the Index. The Index is designed to provide capital appreciation by thoroughly evaluating companies based on a variety of investment merit criteria, including price momentum, earnings momentum, quality, management action, and value. The Index is comprised of securities of 30 US biotechnology and genome companies. These are companies that are principally engaged in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes and companies that benefit significantly from scientific and technological advances in biotechnology and genetic engineering and research. The Fund and the Index are rebalanced and reconstituted quarterly in February, May, August and November.

Full PBE Calculator →

MCDConsumer Discretionary

McDonald's Corporation operates and franchises McDonald's restaurants in the United States and internationally. Its restaurants offer hamburgers and cheeseburgers, chicken sandwiches and nuggets, wraps, fries, salads, oatmeal, shakes, desserts, sundaes, soft serve cones, bakery items, soft drinks, coffee, and beverages and other beverages, as well as breakfast menu, including biscuit and bagel sandwiches, breakfast burritos, hotcakes, and other sandwiches. As of December 31, 2021, the company operated 40,031 restaurants. McDonald's Corporation was founded in 1940 and is headquartered in Chicago, Illinois.

Full MCD Calculator →
📬

Get this PBE vs MCD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PBE vs SCHDPBE vs JEPIPBE vs OPBE vs KOPBE vs MAINPBE vs YUMPBE vs QSRPBE vs SBUX

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.